Gain Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Gain Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q3 2024.
  • Gain Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 26.5M shares, a 109% increase year-over-year.
  • Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 13M shares, a 9.49% increase from 2022.
  • Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 11.9M shares, a 16.9% increase from 2021.
  • Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 10.2M shares, a 279% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 26.5M +13.8M +109% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 19.2M +6.83M +55.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 18M +6.04M +50.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 13M +1.13M +9.49% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 12.7M +818K +6.88% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 12.4M +504K +4.24% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 11.9M +51.7K +0.44% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 11.9M +1.72M +16.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 11.9M +6.62K +0.06% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 11.9M +6.91K +0.06% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 11.9M +7.01M +144% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 10.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 11.9M +8.67M +271% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 11.9M +9.89M +499% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 4.87M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 3.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 1.98M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.